Epigral Q4 Results Live : Epigral announced their Q4 results on 22 Apr, 2024, with a 6.68% decrease in revenue but a 0.71% increase in profit year-over-year.
In comparison to the previous quarter, the company saw a significant growth with an 11.26% increase in revenue and a substantial 57.44% rise in profit.
The Selling, general & administrative expenses showed a notable increase by 13.43% quarter-over-quarter and a 12.99% year-over-year growth.
Operating income also witnessed a strong performance, rising by 36.05% sequentially and 0.39% year-over-year.
The Earnings Per Share (EPS) for Q4 stood at ₹18.6, reflecting a 0.72% increase year-over-year.
Epigral’s stock performance has been impressive with a 6.84% return in the last week, 53.14% return in the last 6 months, and 43.18% Year-to-Date return.
Currently, Epigral commands a market cap of ₹5812.45 Cr, with a 52-week high/low of ₹1424.9 and ₹862.05 respectively.
| Period | Q4 | Q3 | Q-o-Q Growth | Q4 | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 524.63 | 471.52 | +11.26% | 562.18 | -6.68% |
| Selling/ General/ Admin Expenses Total | 25.52 | 22.5 | +13.43% | 22.59 | +12.99% |
| Depreciation/ Amortization | 30.38 | 30.88 | -1.63% | 30.13 | +0.82% |
| Total Operating Expense | 399.62 | 379.63 | +5.27% | 437.64 | -8.69% |
| Operating Income | 125.02 | 91.89 | +36.05% | 124.53 | +0.39% |
| Net Income Before Taxes | 113.46 | 73.94 | +53.46% | 110.07 | +3.08% |
| Net Income | 77.28 | 49.08 | +57.44% | 76.73 | +0.71% |
| Diluted Normalized EPS | 18.6 | 11.81 | +57.49% | 18.47 | +0.72% |
FAQs
Question : What is the Q4 profit/Loss as per company?
Ans : ₹77.28Cr
Question : What is Q4 revenue?
Ans : ₹524.63Cr
Stay updated on quarterly results with our results calendar
Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it’s all here, just a click away! Login Now!
Download The Mint News App to get Daily Market Updates & Live Business News.
Published: 24 Apr 2024, 03:29 AM IST